Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 59 out of 100. Digital health tools

Topic: Brain imaging, connectivity and assessment

Alzheimer's Disease (AD) is one of the leading causes of death in developed countries. From a research point of view, impressive results have been reported using computer-aided algorithms, but clinically no practical diagnostic method is available. In recent years, deep models have become popular, especially in dealing with images. Since 2013, deep learning has begun to gain considerable attention in AD detection research, with the number of published papers in this area increasing drastically since 2017. Deep models have been reported to be more accurate for AD detection compared to general machine learning techniques. Nevertheless, AD detection is still challenging, and for classification, it requires a highly discriminative feature representation to separate similar brain patterns. This paper reviews the current state of AD detection using deep learning. Through a systematic literature review of over 100 articles, we set out the most recent findings and trends. Specifically, we review useful biomarkers and features (personal information, genetic data, and brain scans), the necessary pre-processing steps, and different ways of dealing with neuroimaging data originating from single-modality and multi-modality studies. Deep models and their performance are described in detail. Although deep learning has achieved notable performance in detecting AD, there are several limitations, especially regarding the availability of datasets and training procedures.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Ebrahimighahnavieh, M. A., Luo, S., & Chiong, R. (2020). Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review. Computer methods and programs in biomedicine. https://doi.org/10.1016/j.cmpb.2019.105242

Vancouver

Ebrahimighahnavieh MA, Luo S, Chiong R. Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review. Computer methods and programs in biomedicine. 2020. doi:10.1016/j.cmpb.2019.105242. PMID: 31837630.

BibTeX

@article{ebrahimighahnavieh2020-31837630,
  author  = {Ebrahimighahnavieh, M. A. and Luo, S. and Chiong, R.},
  title   = {{Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review}},
  journal = {Computer methods and programs in biomedicine},
  year    = {2020},
  doi     = {10.1016/j.cmpb.2019.105242},
  pmid    = {31837630},
  url     = {https://doi.org/10.1016/j.cmpb.2019.105242}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Study details

How this study scored 59/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 12 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read 0 of 2. 34 of the 58 points it could be judged on, which is 59 of 100. Total 59 of 100.34 of the 58 points we could judge = 59 of 100

Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 34 of the 58 points we could judge it on, which is 59 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Computer methods and programs in biomedicine)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 12 / 12 A systematic review of all the studies on the question (from PubMed type “Systematic Review”)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2020 — within 10 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 A review of other studies — randomisation is not credited here
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 31837630)
Free to read 0 / 2 Behind a paywall — scores zero
Points 34 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 34 of the 58 points we could judge it on is 59 out of 100.
Total 59 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Digital health tools

Also tagged “convolutional”

205 studies in the library carry the topic tag “convolutional”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 205 tagged studies.

Similar studies

More on Digital health tools

See all studies in Digital health tools →